These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3532693)

  • 21. The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.
    Bolte AC; van Eyck J; Strack van Schijndel RJ; van Geijn HP; Dekker GA
    Br J Obstet Gynaecol; 1998 Jul; 105(7):723-31. PubMed ID: 9692412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous diazoxide therapy in hypertensive crisis.
    McDonald WJ; Smith G; Woods JW; Perry HM; Danielson BD
    Am J Cardiol; 1977 Sep; 40(3):409-15. PubMed ID: 331925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of dihydralazine with furosemide in hypertonic patients.
    Siegmund W; Kairies M; Franke G; Donner I; Biebler KE
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):148-51. PubMed ID: 3557742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertensive crisis and its treatment].
    de Châtel R
    Z Gesamte Inn Med; 1980 Oct; 35(19):suppl 106-9. PubMed ID: 7210750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the cardiac, renal and endocrine effects of converting enzyme inhibition with those of a classical triple therapy in experimental renal hypertension].
    Dussaule JC; Michel JB; Auzan C; Alhenc-Gélas F; Corvol P; Ménard J
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1220-5. PubMed ID: 6098234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in plasma volume and electrolytes after treatment of therapy-resistant hypertension with diazoxide and furosemide].
    Kiesewetter R; Cebulla P; Herrmann RM; Stoll W
    Z Gesamte Inn Med; 1981 Sep; 36(17):627-30. PubMed ID: 7345809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of aggressive therapy in the hypertensive patient with azotemia.
    Mroczek WJ; Davidov M; Gavrilovich L; Finnerty FA
    Circulation; 1969 Dec; 40(6):893-904. PubMed ID: 5387363
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of hypertensive crises].
    Haas Th; Denkl P
    Fortschr Med; 1977 Apr; 95(15):997-9. PubMed ID: 858582
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of arterial hypertension in elderly patients].
    Halawa B
    Wiad Lek; 1981 Aug; 34(16):1357-62. PubMed ID: 7041432
    [No Abstract]   [Full Text] [Related]  

  • 30. Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome.
    Bolte AC; van Eyck J; Kanhai HH; Bruinse HW; van Geijn HP; Dekker GA
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):371-7. PubMed ID: 9988803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current treatment of arterial hypertension].
    Faulhaber HD; Linss G
    Z Arztl Fortbild (Jena); 1977 Apr; 71(8):378-82. PubMed ID: 17954
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of hypertension with obsilazin].
    Sirakova V; Penkov N; Kaponov Kh; Dimitrov G
    Vutr Boles; 1986; 25(2):32-6. PubMed ID: 2872755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive effect of diazoxide given intravenously in small repeated doses.
    McNair A; Andreasen F; Nielsen PE
    Eur J Clin Pharmacol; 1983; 24(2):151-6. PubMed ID: 6840160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug-induced readjustment of therapy-resistant hypertension].
    Kiesewetter R; Herrmann R
    Z Gesamte Inn Med; 1978 Nov; 33(21):793-5. PubMed ID: 735253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diazoxide in the management of severe hypertension after electroconvulsive therapy.
    Kraus RP; Remick RA
    Am J Psychiatry; 1982 Apr; 139(4):504-5. PubMed ID: 7065299
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension.
    Suonio S; Saarikoski S; Tahvanainen K; Pääkkönen A; Olkkonen H
    Am J Obstet Gynecol; 1986 Jul; 155(1):122-5. PubMed ID: 3728580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quality of blood pressure control in general practice and in the HOT study. French Research Group HOT (Hypertension Optimal Treatment)].
    Raveau-Landon C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1179-81. PubMed ID: 8572869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diazoxide and furosemide in the treatment of hypertensive emergencies (author's transl)].
    Duraković Z; Bakran V; Vrhovac B; Gjurasin M
    Lijec Vjesn; 1978 Apr; 100(4):244-8. PubMed ID: 672387
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG; Chavanu KJ; Xu J
    Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.